Direxion Daily S&P Biotech Bull 3X ETF
LABU
21 hedge funds and large institutions have $22.2M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 9 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0.06% less ownership
Funds ownership: 0.32% → 0.26% (-0.06%)
22% less funds holding
Funds holding: 27 → 21 (-6)
29% less call options, than puts
Call options by funds: $24.8M | Put options by funds: $34.8M
46% less capital invested
Capital invested by funds: $41.1M → $22.2M (-$18.9M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$3.21M |
| 2 |
Citigroup
New York
|
+$2.71M |
| 3 |
Morgan Stanley
New York
|
+$1.76M |
| 4 |
CG
Cutler Group
San Francisco,
California
|
+$1.54M |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$494K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$4.76M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.55M |
| 3 |
EWA
Exencial Wealth Advisors
Oklahoma City,
Oklahoma
|
-$2.32M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.43M |
| 5 |
IMC Chicago
Chicago,
Illinois
|
-$1.43M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
XS
26
XR Securities
Chicago,
Illinois
| – | -$380K | -379 | Closed |
|
27
Walleye Trading
New York
| – | -$20K | -20 | Closed |
|
|
BWM
28
BerganKDV Wealth Management
Bloomington,
Minnesota
| – | -$5K | -5 | Closed |
|
|
TCM
29
Tradewinds Capital Management
Bellingham,
Washington
| – | -$2K | -2 | Closed |
|
|
JFA
30
JNBA Financial Advisors
Bloomington,
Minnesota
| – | -$1K | -1 | Closed |
|
LABU Hedge Fund Activity: Q3 2019 in Review
21 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q3 2019, worth a combined $22.2M — down 46% from $41.1M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of LABU and 3 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 6 added.
The largest buyer was Citadel Advisors, adding an estimated $3.21M. The largest seller was Jane Street, exiting entirely with an estimated $4.76M sold.
- 21 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q3 2019, down from 27 in Q2 2019.
- Funds reported $22.2M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q3 2019, down 46% quarter-over-quarter.
- 3 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q3 2019 and 9 closed out, a net change of -6 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q3 2019 was Citadel Advisors, an estimated $3.21M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q3 2019 was Jane Street, an estimated $4.76M sold.
Based on aggregated 13F filings for Q3 2019.